Examination of changes in TGF-beta1 and KL-6 expression over time in patients with chronic hepatitis C by AT-II receptor blocker therapy.
Kurihara
Takeshi
T
Maeda
Atsushi
A
Shigemoto
Mutsuo
M
Yamashita
Katsuko
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000941:Antigens / Q000096:biosynthesis*; D000951:Antigens, Neoplasm; D005260:Female; D006023:Glycoproteins / Q000096:biosynthesis*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018396:Mucin-1; D009077:Mucins / Q000096:biosynthesis*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*
D047228:Angiotensin II Type 1 Receptor Blockers; D000941:Antigens; D000951:Antigens, Neoplasm; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D016212:Transforming Growth Factor beta